CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 75 filers reported holding CYTEK BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,574,116 | -28.3% | 16,770,673 | +10.9% | 0.00% | -25.0% |
| Q2 2023 | $129,188,893 | +69.6% | 15,127,505 | +82.5% | 0.00% | +100.0% |
| Q1 2023 | $76,159,799 | -10.9% | 8,287,247 | -1.0% | 0.00% | -33.3% |
| Q4 2022 | $85,433,268 | -26.7% | 8,367,607 | +5.7% | 0.00% | -25.0% |
| Q3 2022 | $116,549,000 | +52.2% | 7,917,642 | +10.9% | 0.00% | +100.0% |
| Q2 2022 | $76,584,000 | +16.6% | 7,137,392 | +17.1% | 0.00% | 0.0% |
| Q1 2022 | $65,687,000 | +69.8% | 6,093,340 | +157.1% | 0.00% | +100.0% |
| Q4 2021 | $38,686,000 | -2.6% | 2,370,459 | +27.8% | 0.00% | 0.0% |
| Q3 2021 | $39,711,000 | – | 1,854,743 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $22,533,000 | 12.24% |
| Miura Global Management | 1,649,400 | $17,698,000 | 12.14% |
| RA Capital Management | 13,381,054 | $143,578,000 | 3.83% |
| HHLR ADVISORS, LTD. | 8,757,030 | $93,963,000 | 2.01% |
| PURA VIDA INVESTMENTS, LLC | 477,164 | $5,120,000 | 0.30% |
| RTW INVESTMENTS, LP | 916,838 | $9,838,000 | 0.25% |
| Glenview Capital Management | 500,000 | $5,365,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 73,743 | $791,000 | 0.12% |
| Parkwood LLC | 42,292 | $454,000 | 0.08% |
| Point72 Asset Management, L.P. | 1,536,079 | $16,482,000 | 0.07% |